Amaurosis-hypertrichosis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1021OMIM:204110H35.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Amaurosis-hypertrichosis syndrome is an extremely rare genetic disorder characterized by the combination of congenital amaurosis (blindness or severe visual impairment present from birth) and hypertrichosis (excessive hair growth). The condition primarily affects the visual system and the integumentary system (skin and hair). Congenital amaurosis in this syndrome is related to retinal dystrophy, meaning the light-sensing cells of the retina do not function properly, leading to severe vision loss or complete blindness from birth or early infancy. The hypertrichosis component involves abnormally increased hair growth, which may be generalized or localized to certain body areas. This syndrome has been described in only a very small number of families in the medical literature, making detailed characterization of its full clinical spectrum challenging. The association of these two features — congenital blindness due to retinal dysfunction and excessive body hair — distinguishes it from isolated Leber congenital amaurosis or other forms of congenital retinal dystrophy. Additional clinical features may vary among affected individuals. There is currently no cure for amaurosis-hypertrichosis syndrome. Management is supportive and symptomatic, focusing on visual rehabilitation, low-vision aids, educational support for visually impaired individuals, and cosmetic management of hypertrichosis if desired. Genetic counseling is recommended for affected families. Given the rarity of the condition, affected individuals may benefit from referral to specialized centers with expertise in inherited retinal diseases and rare genetic syndromes.

Clinical phenotype terms— hover any for plain English:

Cone/cone-rod dystrophyHP:0000548High hypermetropiaHP:0008499
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Amaurosis-hypertrichosis syndrome.

View clinical trials →

No actively recruiting trials found for Amaurosis-hypertrichosis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Amaurosis-hypertrichosis syndrome community →

No specialists are currently listed for Amaurosis-hypertrichosis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Amaurosis-hypertrichosis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Amaurosis-hypertrichosis syndromeForum →

No community posts yet. Be the first to share your experience with Amaurosis-hypertrichosis syndrome.

Start the conversation →

Latest news about Amaurosis-hypertrichosis syndrome

No recent news articles for Amaurosis-hypertrichosis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Amaurosis-hypertrichosis syndrome

What is Amaurosis-hypertrichosis syndrome?

Amaurosis-hypertrichosis syndrome is an extremely rare genetic disorder characterized by the combination of congenital amaurosis (blindness or severe visual impairment present from birth) and hypertrichosis (excessive hair growth). The condition primarily affects the visual system and the integumentary system (skin and hair). Congenital amaurosis in this syndrome is related to retinal dystrophy, meaning the light-sensing cells of the retina do not function properly, leading to severe vision loss or complete blindness from birth or early infancy. The hypertrichosis component involves abnormally

How is Amaurosis-hypertrichosis syndrome inherited?

Amaurosis-hypertrichosis syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Amaurosis-hypertrichosis syndrome typically begin?

Typical onset of Amaurosis-hypertrichosis syndrome is neonatal. Age of onset can vary across affected individuals.